Results 81 to 90 of about 1,194 (166)

Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]

Nephrology (Carlton)
Inoue R, Yamaguchi S, Okada A, Yamauchi T, Kadowaki T, Nangaku M.   +5 more
europepmc   +1 more source

Correction: Prescribing Cascades with Recommendations to Prevent or Reverse Them:A Systematic Review [PDF]

Adrien, Oriane, Denig, Petra, Hugtenburg, Jacqueline G, Karapinar-Carkıt, Fatma, McCarthy, Lisa M, Mohammad, Atiya K, Priester-Vink, Simone, van den Bemt, Patricia M L A, Visscher, Robbert   +8 more
core   +1 more source

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China. [PDF]

Arthritis Rheumatol
Sun J, Wang Y, Cheng Y, Guo D, Hu J, Liu D, Gao Z, Li C, Lu Y, Kong X, Liu Y, Jiang Z, Yi B, Zhang H, Xu B, Yu S, Kokan R, Ishikawa K, Kawakatsu M, Zhang Z.   +19 more
europepmc   +1 more source

Ethnomedicinal knowledge and novel folk claims from Sunderbani Block, Rajouri District, Jammu & Kashmir, India

Medicinal plants have been essential to indigenous practices since ancient times. The Sunderbani region in Jammu and Kashmir (India) hosts a wealth of medicinal plants and traditional wisdom.
Anjum, Talat, Hussain, Jaffer, Kumar, Gopesh, Nagayya, Shiddamallayya, Shah, Aditya B., Srikanth, Narayanam, Tamchos, Sonam   +6 more
core   +1 more source

Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study. [PDF]

Sci Rep
Kim MJ, Pyo JY, Choi SR, Shin A, Choung H, Ha YJ, Lee YJ, Lee EB, Kang EH.   +8 more
europepmc   +1 more source

Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in Adolescents. [PDF]

Int J Rheum Dis
Li C, Lu J, Lyu Z, Chen H, Su B, Ban B, Mao J, Liu P, Cheng Z, Zhu J, Wan N, Chen X, Gong C, Ye P, Sun M, Sun W, Zhang H, Yin H, Jiang X, Wang Q, Chen Y, Lin HY, Mi J, Zhao J.   +23 more
europepmc   +1 more source

Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase. [PDF]

Rheumatology (Oxford)
Troum OM, Duong M, Obermeyer K, Padnick-Silver L, LaMoreaux B.   +4 more
europepmc   +1 more source

2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities. [PDF]

Int J Rheum Dis
Li C, Sun M, Liu Z, Li D, Wang C, Tian Z, Dai Y, Feng Z, Xu C, Zhao D, Wei F, Ban B, Xie C, An Z, Liu J, Li Z, He Y, Li X, Yan F, Han L, Ma L, Cheng X, Liu T, Luo X, Cui L, Gong Y, Wang C, Chen Y, Lyu Z, Yip RML, Zhao J.   +30 more
europepmc   +1 more source

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study. [PDF]

J Intern Med
Jeon M, Cho Y, Bea S, You W, Cho SK, Ryu S, Chang Y, Shin JY.   +7 more
europepmc   +1 more source

Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout. [PDF]

J Manag Care Spec Pharm
Rizk JG, Qato DM, Bingham CO, dosReis S.
europepmc   +1 more source